18th European Molecular Imaging Meeting 2023

Mar 13th, 2023Mar 16th, 2023
Salzburg, 05
AT
https://www.emim.eu
Phone:+4922178966180
It is with great pleasure to invite you to Salzburg, Austria for the 18th European Molecular Imaging Meeting 2023.
Latest in Home
Doctors Residents Student Education 400
EBR accepts registrations for EDiR, launches EDiR Academy
July 31, 2026
Three months after thermal ablation, contrast-enhanced CT (A, B) shows post-treatment changes without clear local progression, while FDG-PET/CECT (C–F) reveals focal uptake suspicious for recurrence.
FDG-PET/CT sharpens surveillance after colorectal liver metastasis treatment
July 30, 2026
Pexels Thirdman 8940356 (1)
Scottish team designs 10-year sustainability model for preclinical imaging
July 29, 2026
Overview of the hallmarks of cancer and the imaging modalitites that are being used to assess them.
ESMI review maps cancer biology ahead of TOPIM 2026
July 28, 2026
More in Home
EBR accepts registrations for EDiR, launches EDiR Academy
By AuntMinnieEurope.com staff writers
July 31, 2026
Doctors Residents Student Education 400
FDG-PET/CT sharpens surveillance after colorectal liver metastasis treatment
By Claudia Tschabuschnig
A Dutch study found that adding metabolic imaging to contrast-enhanced CT improved early detection of local tumor progression after liver ablation or resection, including disease missed by CT alone.
July 30, 2026
Three months after thermal ablation, contrast-enhanced CT (A, B) shows post-treatment changes without clear local progression, while FDG-PET/CECT (C–F) reveals focal uptake suspicious for recurrence.
Scottish team designs 10-year sustainability model for preclinical imaging
By Claudia Tschabuschnig
A Scottish team has designed a theoretical 10-year strategy for keeping a multimodal preclinical imaging facility financially viable, operationally resilient, environmentally responsible, and accessible to researchers.
July 29, 2026
Pexels Thirdman 8940356 (1)
ESMI review maps cancer biology ahead of TOPIM 2026
By Claudia Tschabuschnig
Ahead of TOPIM 2026, a new Nature Reviews Cancer article explores how molecular imaging can reveal the biological processes driving tumor growth, resistance, and immune evasion.
July 28, 2026
Overview of the hallmarks of cancer and the imaging modalitites that are being used to assess them.
Behind the Editors' desk: How AI Is reshaping scientific publishing
By Claudia Tschabuschnig
From peer review to paper mills, the Editors' Forum explored how AI is transforming scientific publishing.
July 27, 2026
Forum
Societies host events for MR Safety Week
By AuntMinnie.com staff writers
Observances trace to the 2001 death of Michael Colombini.
July 27, 2026
Safety
SPECT/CT viable over PET/CT for high-risk prostate cancer staging
By Will Morton
Considering its broader accessibility, Tc-99m MIP-1404 CZT SPECT/CT may represent a practical alternative for primary staging.
July 24, 2026
Maximum intensity projection of Ga-68 PSMA-11 PET/CE-CT (A), Tc-99m MIP-1404 CZT SPECT/CT (B) and Tc-99m HDP CZT SPECT/CT (C) imaging. Ga-68 PSMA-11 PET/CE-CT and Tc-99m MIP-1404 CZT SPECT/CT showing tracer uptake in lymph nodes below the iliac bifurcation and above, paraaortic and left supraclavicular, bone uptake in the right proximal femur and right scapula (arrows). Tc-99m HDP CZT SPECT/CT did not show any uptake suspicious for metastatic disease. No sclerotic lesions suspicious of metastases were detected by the CT component in any of the studies. Fusion axial imaging of Ga-68 PSMA-11 PET/CE-CT (D) and Tc-99m MIP-1404 CZT SPECT/CT (E) showing uptake in lymph nodes in the left pelvic area below the iliac bifurcation (arrows). Fusion axial imaging of Ga-68 PSMA-11 PET/CE-CT (F) and Tc-99m MIP-1404 CZT SPECT/CT (G) showing uptake in the right proximal femur, not detected by Tc-99m HDP CZT SPECT/CT (H), (arrows).
Gender disparities persist in radiology despite progress, ESR survey finds
By Claudia Tschabuschnig
Women were far more likely than men to view gender as a career disadvantage, while differences between European regions suggest opportunities for improvement.
July 23, 2026
Pexels Cristian Rojas 8460378
CT dose, not FDG, drives chromosome damage during PET/CT
By Claudia Tschabuschnig
The findings suggest that standard-dose CT should be reserved for clearly justified diagnostic indications.
July 22, 2026
New research suggests the CT component of PET/CT, rather than the FDG tracer, is associated with measurable chromosome damage.
Are chest x-rays useful in children with recurrent wheezing?
By Will Morton
Recurrent wheezing affects roughly half of all children under three years old.
July 22, 2026
Preschoolers
EU AI Act brings radiology AI oversight into daily practice
By Claudia Tschabuschnig
A new opinion paper calls on European imaging departments to strengthen AI auditing and monitoring in patient care.
July 21, 2026
The European Parliament in Brussels approved the EU AI Act in 2024, establishing a risk-based regulatory framework for artificial intelligence, including high-risk medical AI systems.
European guideline aims to harmonize bone sarcoma imaging
By Claudia Tschabuschnig
Rare bone cancers have lacked a common imaging framework across pediatric and adult care.
July 20, 2026
Illustration of musculoskeletal x-ray imaging. New European guidance aims to harmonize imaging protocols for osteosarcoma and Ewing sarcoma.
Page 1 of 88
Next Page